← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2012Last known activity
Oct 1, 2021
Timeline
1980s
- Jan 1, 1985
IRCCS Eugenio Medea— Founded
Drugs by trial phase (7 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT06005506CollaboratorN/AOct 1, 2021
- NCT04273165Lead sponsorPhase 2Mar 20, 2020
- NCT04272021Lead sponsorPhase 4Apr 13, 2018
- NCT04272021Sponsor investigatorPhase 4Apr 13, 2018
- NCT03888664Lead sponsorPhase 2Jun 26, 2016
- NCT03888664Overall official - principal investigatorPhase 2Jun 26, 2016
- NCT03888664Reponsible party - principal investigatorPhase 2Jun 26, 2016
- NCT01796262Reponsible party - principal investigatorPhase 3Jun 1, 2012
- NCT01796262Overall official - principal investigatorPhase 3Jun 1, 2012
- NCT01796262Lead sponsorPhase 3Jun 1, 2012
Details
- Founded
- Bosisio Parini, IT Jan 1, 1985
- Last known activity
- Oct 1, 2021